Immunotherapy for Contact Dermatitis Using Co-signal Regulation
Compounds, compositions and methods for immunotherapy in contact dermatitis. Compounds and compositions (e.g. monoclonal antibodies) that stimulate the LAIR-1 expression pathway in LAIR-1 expressing immune cells and are useful for preventing or treating contact dermatitis are provided.
Attached files:Patents:WO 2,010,078,580
Inventor(s):
TAMADA KOJI [US]
Type of Offer:
Licensing
« More Medical Patents